Redeye’s estimates on group level were right on target this time. Railcare’s Q1 sales are slightly up and earnings unchanged Y/Y. However, we note a couple of interesting deviations in the different business segments. The overall outlook appears favorable, with stable market conditions. The report will most likely only cause minor changes to our financial forecasts and valuation.
LÄS MER